Trial · NCT04428359
Results by group58
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 58
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Efficacy of IL MMR and IL Vitamin D3 in Treatment of Warts | Measles, Mumps, Rubella Vaccine | Complete response | 25 | Participants | |
| Efficacy of IL MMR and IL Vitamin D3 in Treatment of Warts | Vitamin D3 | Complete response | 22 | Participants | |
| Efficacy of IL MMR and IL Vitamin D3 in Treatment of Warts | Measles, Mumps, Rubella Vaccine | Excellent response | 2 | Participants | |
| Efficacy of IL MMR and IL Vitamin D3 in Treatment of Warts | Vitamin D3 | Excellent response | 6 | Participants | |
| Efficacy of IL MMR and IL Vitamin D3 in Treatment of Warts | Measles, Mumps, Rubella Vaccine | Good response | 3 | Participants | |
| Efficacy of IL MMR and IL Vitamin D3 in Treatment of Warts | Vitamin D3 | Good response | 1 | Participants | |
| Efficacy of IL MMR and IL Vitamin D3 in Treatment of Warts | Measles, Mumps, Rubella Vaccine | Poor or no response | 1 | Participants | |
| Efficacy of IL MMR and IL Vitamin D3 in Treatment of Warts | Vitamin D3 | Poor or no response | 1 | Participants | |
| Number of Participants in Each Education Level Group | Measles, Mumps, Rubella Vaccine | Graduate and higher | 2 | Participants | |
| Number of Participants in Each Education Level Group | Vitamin D3 | Graduate and higher | 4 | Participants | |
| Number of Participants in Each Education Level Group | Measles, Mumps, Rubella Vaccine | Intermediate | 4 | Participants | |
| Number of Participants in Each Education Level Group | Vitamin D3 | Intermediate | 2 | Participants | |
| Number of Participants in Each Education Level Group | Measles, Mumps, Rubella Vaccine | High School | 16 | Participants | |
| Number of Participants in Each Education Level Group | Vitamin D3 | High School | 20 | Participants | |
| Number of Participants in Each Education Level Group | Measles, Mumps, Rubella Vaccine | Middle School | 6 | Participants | |
| Number of Participants in Each Education Level Group | Vitamin D3 | Middle School | 3 | Participants | |
| Number of Participants in Each Education Level Group | Measles, Mumps, Rubella Vaccine | Primary and informal | 3 | Participants | |
| Number of Participants in Each Education Level Group | Vitamin D3 | Primary and informal | 1 | Participants | |
| Number of Participants in Each Occupation Group | Measles, Mumps, Rubella Vaccine | Semiprofessional | 1 | Participants | |
| Number of Participants in Each Occupation Group | Vitamin D3 | Semiprofessional | 3 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04428359/results